Text Size: A A A      Contrast:       
 

List of Clinical Trials
Showing items 1 - 15 of 16 in List of Clinical Trials

  • DRCR I

    Trial Description Summary: The research study is going to address the swelling and/or leakage of blood vessels in the small central part of the retina (called Macular Edema) in diabetic patients.

    Categories: Completed, Diabetic Retinopathy
    learn more
  • DRCR M

    Trial Description Summary: A randomized controlled study to determine if formal diabetes education provided in an ophthalmology office vs. no formal education given in an ophthalmology office will lead to patients achieving better glycemic control.• 

    Categories: Completed, Diabetic Retinopathy
    learn more
  • DRCR N

    Trial Description Summary: The study is being conducted to determine if intravitreal injections of ranibizumab decrease the proportion of eyes  in which vitrectomy is performed compared with saline injections in eyes presenting with vitreous hemorrhage from proliferative diabetic retinopathy.

    Categories: Completed, Diabetic Retinopathy
    learn more
  • DRCR R

    Trial Description Summary:  A Phase II multi-center double masked randomized study to assess the effects of topical NSAID, Nepafenac 0.1%, 3 times a day on macular retinal volume compared with placebo in eyes with non-central DME. 

    Categories: Completed, Diabetic Retinopathy
    learn more
  • DRCR S

    Trial Description Summary: A Phase III prospective, multicenter randomized clinical trial to determine if visual acuity at 2 years in eyes with PDR that receive ranibizumab with deferred PRP  are non-inferior to those eyes that receive standard PRP therapy.

    Categories: Completed, Diabetic Retinopathy
    learn more
  • DRCR T

    Trial Description Summary: Study to compare efficacy and safety of (a) 2.0 mg intravitreal Aflibercept (b) 1.25mg intravitreal Bevacizumab and (c) 0.5mg intravitreal Ranibizumab

    Categories: Completed, Diabetic Retinopathy
    learn more
  • DRCRnet K

    Trial Description Summary: The primary goal of this study is to learn more about the changes in vision and the swelling of the macula from laser treatment of diabetic macular edema.

    Categories: Completed, Diabetic Retinopathy
    learn more
  • Lilly MBCU

    Trial Description Summary: A study to evaluate the safety and effectiveness of the use of an oral experimental drug (Ruboxistaurin) in the reduction of central retinal thickening

    Categories: Completed, Diabetic Retinopathy
    learn more
  • Pfizer DME

    Trial Description Summary: Phase 2 efficacy and safety study of oral chemokine CCR2/5 antagonist (currently called PF-04634817) versus Lucentis in adults with diabetic macular edema.

     

    Categories: Completed, Diabetic Retinopathy
    learn more